Professor
Institut Universitaire du Cancer de Toulouse
Toulouse, Midi-Pyrenees, France
IDENTIFICATION
Gomez-Brouchet Anne ; Marital status: Mascard
14/02/1968 in Toulouse
PU-PH exceptional class (MD, PHD); Academic excellence bonus since 2020
Pathologist and researcher
Email: Gomez.anne@chu-toulouse.fr; ORCID: 000_0003_1223_8393
Adress: Toulouse University Hospital, University Cancer Institute (IUCT)
- IUCT Pathology Department. Pr Pierre Brousset : 1 avenue Irène Joliot-Curie, site oncopole ; Eq 19. Dr F Chibon. ONCOSARC CRCT, UMR 1037 Inserm/UT3, ERL 5294 CNRS, 2 avenue Hubert Curien CS 53717 Université Paul Sabatier ; 1 avenue du Prof. Jean-Poulhès TSA 50032
EXPERTISE
- BONE AND SOFT TISSUE TUMORS (since 2004)
- GFPO, SFCE, NETSARC, RESOS
- VICE- PRESIDENT OF THE EMSOS MEETING, LEAD SUBGROUP OF FOSTER CONSORTIUM
- MEMBER OF THE BOOM CONSORTIUM
- DIRECTOR OF THE CANCER BIOBANK of IUCT, since 2014
EDUCATIONAL INVESTMENT
- FRANCE: DFGSM3, DES DESC, MASTERS, EPU, DU, DIU, Various learned societies: AIP, SFP
- ABROAD: MOROCCO, ATETAM, EPU VIETNAM , EPU CAMBODIA, JAPAN
SCIENTIFIC ACTIVITIES: BONE TUMOR RESEARCH
- ORAL PRESENTATIONS: GSF-GETO, EMSOS, CTOS, EPOS meeting
- NUMBER OF PUBLICATIONS: 152
1. Aurelie Dutour, ….. and Anne Gomez-Mascard. Microenvironment Matters: Insights from the FOSTER Consortium on Microenvironment-Driven Approaches to Osteosarcoma Therapy. Cancer and metastases Cancer Metastasis Rev. 2025 Apr 10;44(2):44.
2. Gomez-Mascard A, et al Intratumoral Heterogeneity Assessment of the Extracellular Bone Matrix and Immune Microenvironment in Osteosarcoma Using Digital Imaging to Predict Therapeutic Response. Lab Invest. 2024 Sep;104(9):102122.
39098628.
3. Benard C, Le Loarer F, Gomez-Mascard A et al. Comprehensive Molecular Characterization of a Large Series of Calcified Chondroid Mesenchymal Neoplasms Widening Their Morphologic Spectrum. Am J Surg Pathol. 2024 Aug 1;48(8):991-1004.
4. Nicolle R, Ayadi M, Gomez-Brouchet A, et al Nat Commun. 2019 Oct 11;10(1):4622.
5. Bousquet M, …Gomez-Brouchet A. Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations. Ann Oncol. 2016 Apr;27(4):738-44.
Friday, November 14, 2025
10:30 AM - 12:00 PM EST
Disclosure information not submitted.
